Literature DB >> 16606610

Estrogen receptor alpha mediates 17alpha-ethynylestradiol causing hepatotoxicity.

Yukio Yamamoto1, Rick Moore, Holly A Hess, Grace L Guo, Frank J Gonzalez, Kenneth S Korach, Robert R Maronpot, Masahiko Negishi.   

Abstract

Estrogens are known to cause hepatotoxicity such as intrahepatic cholestasis in susceptible women during pregnancy, after administration of oral contraceptives, or during postmenopausal replacement therapy. Enterohepatic nuclear receptors including farnesoid X receptor (FXR), pregnane X receptor (PXR), and constitutive active/androstane receptor (CAR) are important in maintaining bile acid homeostasis and protecting the liver from bile acid toxicity. However, no nuclear receptor has been implicated in the mechanism for estrogen-induced hepatotoxicity. Here Era(-/-), Erb(-/-), Fxr(-/-), Pxr(-/-), and Car(-/-) mice were employed to show that Era(-/-) mice were resistant to synthetic estrogen 17alpha-ethynylestradiol (EE2)-induced hepatotoxicity as indicated by the fact that the EE2-treated Era(-/-) mice developed none of the hepatotoxic phenotypes such as hepatomegaly, elevation in serum bile acids, increase of alkaline phosphatase activity, liver degeneration, and inflammation. Upon EE2 treatment, estrogen receptor alpha (ERalpha) repressed the expression of bile acid and cholesterol transporters (bile salt export pump (BSEP), Na(+)/taurocholate cotransporting polypeptide (NTCP), OATP1, OATP2, ABCG5, and ABCG8) in the liver. Consistently, biliary secretions of both bile acids and cholesterol were markedly decreased in EE2-treated wild-type mice but not in the EE2-treated Era(-/-) mice. In addition, ERalpha up-regulated the expression of CYP7B1 and down-regulated the CYP7A1 and CYP8B1, shifting bile acid synthesis toward the acidic pathway to increase the serum level of beta-muricholic acid. ERbeta, FXR, PXR, and CAR were not involved in regulating the expression of bile acid transporter and biosynthesis enzyme genes following EE2 exposure. Taken together, these results suggest that ERalpha-mediated repression of hepatic transporters and alterations of bile acid biosynthesis may contribute to development of the EE2-induced hepatotoxicity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16606610     DOI: 10.1074/jbc.M602723200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  Engineered three-dimensional liver mimics recapitulate critical rat-specific bile acid pathways.

Authors:  Christopher J Detzel; Yeonhee Kim; Padmavathy Rajagopalan
Journal:  Tissue Eng Part A       Date:  2010-12-19       Impact factor: 3.845

2.  Inhibition of Na+-taurocholate Co-transporting polypeptide-mediated bile acid transport by cholestatic sulfated progesterone metabolites.

Authors:  Shadi Abu-Hayyeh; Pablo Martinez-Becerra; Siti H Sheikh Abdul Kadir; Clare Selden; Marta R Romero; Myrddin Rees; Hanns-Ulrich Marschall; Jose J G Marin; Catherine Williamson
Journal:  J Biol Chem       Date:  2010-02-20       Impact factor: 5.157

3.  Estrogen modulates transactivations of SXR-mediated liver X receptor response element and CAR-mediated phenobarbital response element in HepG2 cells.

Authors:  Gyesik Min
Journal:  Exp Mol Med       Date:  2010-11-30       Impact factor: 8.718

Review 4.  Intrahepatic cholestasis of pregnancy.

Authors:  Victoria Geenes; Catherine Williamson
Journal:  World J Gastroenterol       Date:  2009-05-07       Impact factor: 5.742

5.  Cholesteryl ester transfer protein alters liver and plasma triglyceride metabolism through two liver networks in female mice.

Authors:  Brian T Palmisano; Thao D Le; Lin Zhu; Yoon Kwang Lee; John M Stafford
Journal:  J Lipid Res       Date:  2016-06-27       Impact factor: 5.922

6.  Cholic Acid Feeding Leads to Increased CYP2D6 Expression in CYP2D6-Humanized Mice.

Authors:  Xian Pan; Rebecca Kent; Kyoung-Jae Won; Hyunyoung Jeong
Journal:  Drug Metab Dispos       Date:  2017-02-02       Impact factor: 3.922

7.  27-Hydroxycholesterol promotes cell-autonomous, ER-positive breast cancer growth.

Authors:  Qian Wu; Tomonori Ishikawa; Rosa Sirianni; Hao Tang; Jeffrey G McDonald; Ivan S Yuhanna; Bonne Thompson; Luc Girard; Chieko Mineo; Rolf A Brekken; Michihisa Umetani; David M Euhus; Yang Xie; Philip W Shaul
Journal:  Cell Rep       Date:  2013-11-07       Impact factor: 9.423

8.  Pharmacokinetic Characteristics of Baicalin in Rats with 17α-ethynyl-estradiol-induced Intrahepatic Cholestasis.

Authors:  Cheng-Liang Zhang; Yan-Jiao Xu; Dong Xiang; Jin-Yu Yang; Kai Lei; Dong Liu
Journal:  Curr Med Sci       Date:  2018-03-15

Review 9.  Bile acid transporters in health and disease.

Authors:  A Kosters; S J Karpen
Journal:  Xenobiotica       Date:  2008-07       Impact factor: 1.908

10.  Repression of hepatobiliary transporters and differential regulation of classic and alternative bile acid pathways in mice during pregnancy.

Authors:  Lauren M Aleksunes; Ronnie L Yeager; Xia Wen; Julia Yue Cui; Curtis D Klaassen
Journal:  Toxicol Sci       Date:  2012-08-17       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.